Whirling disease results: no resistance found among rainbow trout

BOZEMAN,MONT--Anglers hoping their favorite fish may become resistant to whirling disease will have to wait longer, according to a recent study of Colorado River rainbow trout.

Several years ago, scientists noted that some offspring of fish born after whirling disease was detected in the Colorado River had lower numbers of spores from the parasite that causes the disease.

Whirling disease attacks the cartilage of young fish, causing them to swirl in a circular pattern and fall victim to predators.

One hypothesis was that those fish may have developed some resistance to the disease, said study co-author Al Zale, assistant leader of the Montana Cooperative Fishery Research Unit at Montana State University in Bozeman.

But a closer look in the laboratory offered no such proof, Zale said.

Scientists saw no difference in the degree of infection among the three groups of fish tested: offspring of adults born before whirling disease was found in the Colorado River; fish whose parents were born after the disease was found; and a control group of domestic rainbows. Scientists analyzed such indicators as spore counts, microscopic disease lesions and swimming performance. Zale said he wasn't surprised by the results.

"We have never seen a fish rapidly develop resistance to a novel disease--ever," he said. By rapidly he means within a few generations.

"There may well be resistance eventually but we're not seeing evidence of it yet. It's something that needs to be looked at again," he added, probably in a few years.

Brown trout are resistant because they co-evolved with the disease parasite over many generations in Northern Europe, far longer than whirling disease has been present in North American rainbow and cutthroat fisheries, Zale said.

The study, which also involved MSU graduate student Eileen Ryce and R. Barry Nehring of the Colorado Division of Wildlife, was published in the Journal of Aquatic A

Contact: Annette Trinity-Stevens
Montana State University

Page: 1 2

Related biology news :

1. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
2. Alzheimers disease is not accelerated aging
3. New molecular link key to cellular proteins involved in cancer progression, other diseases
4. Wildlife Conservation Society hosts public symposium on human-wildlife diseases
5. University of Alberta researcher looks for clues to mysterious disease
6. Study explores gene transfer to modify underlying course of Alzheimers disease
7. Experimental drug shown to block mutant protein causing blood disease
8. Algal contact as a trigger for coral disease
9. Ecology of infectious diseases grants awarded
10. Venn diagram tactics to vet complex disease
11. Genetically modified bacterium as remedy for intestinal diseases

Post Your Comments:

(Date:7/22/2020)... ... July 21, 2020 , ... ... and innovation in technology and compliance, announces a new solution to manage regulated ... ensure every layer of their technology stack complies with FDA and global regulations. ...
(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced the first in a ... the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor profiles ... on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition of ...
(Date:7/1/2020)... ... 2020 , ... Catalent, a global leader in clinical supply ... facility in Minakuchi, located in the Shiga prefecture of Japan. , Operating in ... new 60,000-square-foot facility will provide customers with flexible clinical supply solutions, serving both ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... ... August 13, 2020 , ... ... 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The ... economy’s most dynamic segment—its independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, ...
(Date:8/3/2020)... PHILADELPHIA (PRWEB) , ... August 03, 2020 , ... ... data collection, today announced Jim Corrigan, President and CEO has been named one ... a broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on ...
(Date:7/31/2020)... , ... July 29, 2020 , ... ... can combine up to three different materials for use with CRM, neurostimulation, vascular, ... to three materials to meet specific design requirements, performance, and cost criteria; especially ...
(Date:7/22/2020)... TORONTO (PRWEB) , ... July 22, 2020 , ... Join ... and John Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar ... is the regulating body in China for drugs and medical devices. Specifically, for medical ...
Breaking Biology Technology:
Cached News: